Mirabella Financial Services’s CytomX Therapeutics CTMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-31,400
Closed -$84K 508
2022
Q1
$84K Buy
+31,400
New +$84K 0.01% 439